Please assess the completion status of the following clinical trial:

Trial Title: Outreach for Patients That Are Newly Eligible for Colorectal Cancer Screening

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: HEALTH_SERVICES_RESEARCH
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Patient of Northwestern Medical Faculty Foundation General Internal Medicine~* Patient has a scheduled appointment with a GIM physician in the next several weeks~* Patient will be 50 years old at the time of this appointment~* Patient is male or female~Exclusion Criteria:~* This is the first time the patient is seen in the NMFF GIM clinic~* There is a prior completion of CRC screening noted in EHR.~* There is a prior order placed for CRC screening in EHR.~* Patient has a history of CRC~* Patient has a diagnosis of ulcerative colitis, inflammatory bowel disease, Crohn's Disease, or documented colectomy.

- Gender: ALL
- Minimum Age: 50 Years
- Maximum Age: 50 Years
- Healthy Volunteers: f

Study Arms:
- Usual Care (Type: NO_INTERVENTION): Usual Care. Participants in this arm will receive Usual care until outcome assessment is performed at 6 months following randomization. At that time, they will be sent a letter reminding them to obtain the ordered preventative service test, however no further outcomes will be assessed. Thus, during the course of the study, all participants in this arm will have solely received usual care.
- Behavioral: Letter Only (Type: EXPERIMENTAL): Behavioral: Letter Only Prior to a scheduled upcoming appointment, participants will get a letter signed by their physician that provides brief information about colorectal cancer (CRC) and notes the importance of CRC screening.
- Behavioral: Letter and Educational DVD (Type: EXPERIMENTAL): Behavioral: Letter and Educational DVD Participants will get a letter from their physician that provides brief information about colorectal cancer (CRC) and notes the importance of CRC screening. It will be accompanied by an educational DVD about the screening. The participants will receive this prior to a scheduled upcoming appointment with their physician.

Based on this trial design, predict the completion outcome and termination type (if applicable).